In the BioHarmony Drug Report Database

"Preview" Icon

Eravacycline

Xerava (eravacycline) is a small molecule pharmaceutical. Eravacycline was first approved as Xerava on 2018-08-27. It is used to treat intraabdominal infections in the USA. It has been approved in Europe to treat bacterial infections and infections. Xerava’s patents are valid until 2030-12-28 (FDA).

 

Trade Name

 

Xerava
 

Common Name

 

eravacycline
 

ChEMBL ID

 

CHEMBL1951095
 

Indication

 

bacterial infections, infections, intraabdominal infections
 

Drug Class

 

Antibiotics (tetracycline derivatives)

Image (chem structure or protein)

Eravacycline structure rendering